Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers

James J. Harding, Sarina A. Piha-Paul, Ronak H. Shah, Jessica J. Murphy, James M. Cleary, Geoffrey I. Shapiro, David I. Quinn, Irene Braña, Victor Moreno, Mitesh Borad, Sherene Loi, Iben Spanggaard, Haeseong Park, James M. Ford, Mónica Arnedos, Salomon M. Stemmer, Christelle de la Fouchardiere, Christos Fountzilas, Jie Zhang, Daniel DiPrimeoCasey Savin, S. Duygu Selcuklu, Michael F. Berger, Lisa D. Eli, Funda Meric-Bernstam, Komal Jhaveri, David B. Solit, Ghassan K. Abou-Alfa

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences

Physics & Astronomy